How to buy Global Health shares | A$0.33
Own Global Health shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder .
Global Health Limited is a health information services business based in Australia. Global Health shares (GLH) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.33 – an increase of 43.48% over the previous week. Global Health has a trailing 12-month revenue of around $6.2 million.
How to buy shares in Global Health
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Global Health . Find the share by name or ticker symbol: GLH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Global Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.33, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Global Health . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
How has coronavirus impacted Global Health 's share price?
Since the stock market crash in March caused by coronavirus, Global Health 's share price has had significant positive movement.
Its last market close was $0.33, which is 60.61% up on its pre-crash value of $0.13 and 230.00% up on the lowest point reached during the March crash when the shares fell as low as $0.1.
If you had bought $1,000 worth of Global Health shares at the start of February 2020, those shares would have been worth $900.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,200.00.
Global Health share priceUse our graph to track the performance of GLH stocks over time.
Global Health shares at a glance
|Latest market close||AUDA$0.33|
|52-week range||AUDA$0.1 - AUDA$0.33|
|50-day moving average||AUDA$0.2338|
|200-day moving average||AUDA$0.1981|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.039|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Global Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Global Health price performance over time
|1 week (2020-10-12)||43.48%|
|1 month (2020-09-18)||46.67%|
|3 months (2020-07-17)||15.79%|
|6 months (2020-04-17)||186.96%|
|1 year (2019-10-16)||N/A|
|2 years (2018-10-19)||71.88%|
|3 years (2017-10-19)||7.42%|
|5 years (2015-10-19)||27.31%|
Is Global Health under- or over-valued?
Valuing Global Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Health 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Global Health 's EBITDA
Global Health 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $489,487.
The EBITDA is a measure of a Global Health 's overall financial performance and is widely used to measure a its profitability.
Global Health financials
|Revenue TTM||$6.2 million|
|Gross profit TTM||$1.5 million|
|Return on assets TTM||-1.36%|
|Return on equity TTM||0%|
|Market capitalisation||$9.7 million|
TTM: trailing 12 months
Global Health share dividends
We're not expecting Global Health to pay a dividend over the next 12 months.
Have Global Health 's shares ever split?
Global Health 's shares were split on a 1:15 basis on 2 December 2012. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Global Health shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Global Health shares which in turn could have impacted Global Health 's share price.
Global Health share price volatility
Over the last 12 months, Global Health 's shares have ranged in value from as little as $0.1 up to $0.33. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Global Health 's is 0.5154. This would suggest that Global Health 's shares are less volatile than average (for this exchange).
Global Health overview
Global Health Limited develops, sells, and supports application software for the healthcare sector primarily in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, dental, post-acute care, home and community care, mental health services, and community rehabilitation. The company's products include MasterCare PAS, a patient administration system for appointment scheduling, theatre bookings, and bed management; MasterCare + for practice management, client record, patient engagement, referral management, secure messaging, and scanned medical records; PrimaryClinic, a medical and practice software for general practitioners, specialists, and allied health practitioners; ReferralNet, a message delivery system for information exchange; LifeCard to hold records and track progress. It also provides MasterCare MHAGIC that supports the workflow of mental health service providers; MasterCare Data Warehouse, which enables reporting, analysis, and decision support for managers and clinicians; HotHealth, a patient engagement platform; Patient Portal that directs information required from patients straight into electronic medical record system or PAS; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.
Frequently asked questions
Ask an Expert